• More than 3 million people have disabilities because of leprosy
  • 75 children are diagnosed every day
  • Someone is newly diagnosed with leprosy every 2 minutes
  • Almost 600 people are diagnosed with leprosy everyday
  • India, Brazil and Indonesia have the highest incidence of new leprosy cases

Shrouded in mystery since Biblical times, leprosy is a disease that brings fear and shame to all who are affected. You can join us in replacing that fear with hope as we fight back against leprosy. 

Today leprosy is treated with multi-drug therapy and while it does cure most, it cannot reverse disability, stigma, or mental trauma. The solution is to stop people from contracting leprosy so no one has to face this horrible disease. 

This is why effect:hope supports vaccine and transmission research.  

In 2016 we started R2STOP which stands for Research to Stop Leprosy Transmission. We still do not know how leprosy is transmitted so we are investing in world-renown researchers as they try to answer some of our most urgent questions: How is leprosy transmitted? Who is most at risk? Can a human get leprosy from an animal?

Stopping transmission is key to eliminating leprosy, another is to vaccinate high-risk people for the disease. Alongside the American Leprosy Missions we have committed to develop a specialized vaccine for leprosy. In 2018, the very first dedicated vaccine against leprosy started clinical trials.

Here's how you can help people Worldwide:

Effective Treatments $75

The Stanley Browne Research Facility in India is currently answering our concerns about rapid diagnosis and effective treatments for leprosy. Your gift helps to:

  • Investigate the transmission of leprosy to children from families affected by leprosy
  • Learn the early signs of infection, susceptibility factors and the role of the environment
  • Train field project staff in research methods so they can assist lab researchers with data collection

Stop the Transmission $100

Our work with R2STOP supports research to investigate the real causes of leprosy. You can help researchers answer the following concerns: 

  • Human-to-human transmission
  • Non-human disease reservoirs
  • Genetic risk factors, drug resistance, immune response
  • Genetic characteristics of the disease
$100 x

Launch the Vaccine $50

Through our partnership with IDRI (Infectious Disease Research Institute) you can help us fund the clinical trials required to bring an effective vaccine for leprosy to the people who are most at risk.